Internal Medicine, Infectious Disease · Fortworth, TX
NPI
1326257163
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
9
Medicare group memberships
Hospitals
1
Hospital affiliations
1500 S. Main Street
Fortworth, TX, 76104
Phone (862) 220-0328
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
230 services
Medicare patients, 2024
124
Average age 69
Drug cost, 2024
$5.4M
4,795 prescriptions
Company payments, 2023
$138
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Geeta Manthena was code 99214 (office e&m - established), 93 times for 49 patients. In total Geeta Manthena billed 230 services in 12 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-02-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 93 | 49 | $57.72 | $5,368 |
| 99232 Hospital E&M - Subsequent | Facility | 77 | 47 | $59.77 | $4,602 |
| 99233 Hospital E&M - Subsequent | Facility | 12 | 11 | $90.06 | $1,081 |
By year: 2022 $13K for 196 services; 2023 $14K for 195 services; 2024 $15K for 230 services.
Medicare prescription drug claims, 2024
In 2024, the drug Geeta Manthena prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 456 prescriptions and refills. In total Geeta Manthena wrote 4,795 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 456 | 456 | 68 | $1.7M |
| Amlodipine Besylate Generic | 224 | 516 | 62 | $1,129 |
| Atorvastatin Calcium Generic | 212 | 491 | 65 | $1,158 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 206 | 208 | 31 | $775K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 190 | 220 | 32 | $994K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 143 | 148 | 40 | $3,445 |
| Pantoprazole Sodium Generic | 117 | 242 | 32 | $1,537 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 117 | 117 | 15 | $465K |
| Gabapentin Generic | 117 | 175 | 37 | $2,367 |
| Tivicay Dolutegravir Sodium | 114 | 114 | 16 | $240K |
| Prezcobix Darunavir/Cobicistat | 112 | 112 | 15 | $255K |
| Lisinopril Generic | 93 | 188 | 25 | $572 |
| Fluticasone Propionate Generic | 82 | 118 | 25 | $844 |
| Juluca Dolutegravir/Rilpivirine | 76 | 76 | Under 11 | $254K |
| Ozempic Semaglutide | 64 | 108 | 12 | $95K |
Brand drugs: 1,906 claims; generic drugs: 2,858 claims; opioid claims: 70.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Geeta Manthena $138 ($138 in general payments such as food, travel and fees) from 2 companies. The largest payer was Merck Sharp & Dohme LLC with $122.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.